FDA Inspection
LifeShare Blood CenterLifeShare Blood Center – FDA Inspection, Aug 9, 2019
Record Details
This FDA Inspection record concerns LifeShare Blood Center, with an inspection on August 9, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 66a7889e-019e-40ad-be00-882e82878b55
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1099613
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 606.170(a)Adverse Reaction - Investigations
- 21 CFR 630.40(a)Supplemental results
- 21 CFR 630.10(g)(1)Proof Of Identity
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of LifeShare Blood Center
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 21, 2025 | Not classified | New Orleans District Office | |
| August 31, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 23, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 30, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 17, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for LifeShare Blood Center
- FDA Inspection 1282272 - 2025-08-21
- FDA Inspection 1221056 - 2023-08-31
- FDA Inspection 1017432 - 2017-05-23
- FDA Inspection 936770 - 2015-07-30
- FDA Inspection 754754 - 2011-11-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.